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Abstract 45 
 46 
Aim: The first aim of this study was to systematically review and critically assess 47 
manually-controlled, instrumented spasticity assessment methods that combine 48 
multidimensional signals. The second aim was to extract a set of quantified 49 
parameters that are psychometrically sound to assess spasticity in a clinical setting. 50 
 51 
Method: Electronic databases were searched to identify studies that assessed 52 
spasticity by simultaneously collecting electrophysiological and biomechanical signals 53 
during manually-controlled passive muscle stretches. Two independent reviewers 54 
critically assessed the methodological quality of the psychometric properties of 55 
included studies using the COSMIN guidelines. 56 
 57 
Results: Fifteen studies with instrumented spasticity assessments met all inclusion 58 
criteria. Parameters which integrated electrophysiological signals with joint movement 59 
characteristics were best able to quantify spasticity. There were conflicting results 60 
regarding biomechanical-based parameters that quantify the resistance to passive 61 
stretch. Few methods have been assessed for all psychometric properties. In 62 
particular, more information on absolute reliability and responsiveness for more 63 
muscles is needed. 64 
 65 
Interpretation: Further research is required to determine the correct parameters for 66 
quantifying spasticity based on integration of signals and especially focusing on 67 
decomposing the neural from non-neural contributes to increased joint torque. These 68 
parameters should undergo more rigorous exploration to establish their psychometric 69 
properties for use in a clinical environment. 70 
71 
INTRODUCTION 72 
 73 
Excessive and uncontrolled spasticity causes pain, limits functional recovery and is 74 
thought to cause secondary complications such as contractures and bone 75 
deformities.1 It appears in conditions with upper motor neuron (UMN) syndrome and 76 
is the most common neurological feature in persons with cerebral palsy (CP). Despite 77 
the impact of spasticity and the many therapeutic paradigms aimed at treating it, 78 
there are few clinically-suitable, reliable methods for its assessment. One reason for 79 
the lack of consensus on the assessment method originates from the absence of a 80 
commonly accepted definition for spasticity.2 81 
 82 
In 1954, Tardieu and colleagues described the phenomenon of a ‘spastic catch’ as “a 83 
sudden reactive resistance to a fast passive stretch of a spastic muscle”.3 In 1980, 84 
Lance was the first to define spasticity as “a velocity-dependent increase in tonic 85 
stretch reflexes with exaggerated tendon jerks, resulting from hyper-excitability”.4 86 
Although Lance’s definition is most commonly cited, in routine clinical practice, it is 87 
nearly impossible to distinguish this definition of spasticity from other positive 88 
symptoms of the UMN syndrome. For example, other reflex mechanisms (e.g. 89 
cutaneous or nociceptive) could also contribute to increased muscle activation and 90 
are difficult to distinguish from the proprioceptive reflex mechanisms described by 91 
Lance.5 92 
 93 
Sanger et al. defined spasticity as “resistance to an externally imposed movement 94 
that increases with increasing speed of stretch or rises rapidly above a threshold 95 
speed or joint angle”.6 However, here too distinguishing the resistance caused by 96 
pathological muscle activation due to a hyperactive stretch reflex from the increased 97 
resistance due to passive stiffness is clinically very challenging. Non-neural muscle 98 
and tendon alterations also contribute to reactive resistance, especially in persons 99 
with UMN syndrome.7 Changes of the viscoelastic properties of these structures will 100 
determine both the stiffness and the velocity-dependence of a movement. Thus, it 101 
appears that ‘observed’ spasticity encompasses multiple phenomena and is not a 102 
single pathophysiological entity. In line with this finding, the SPASM consortium 103 
introduced a broader definition for spasticity: “a disordered sensori-motor control, 104 
resulting from UMN lesions, presenting as intermittent or sustained involuntary 105 
activation of muscles’’.5 106 
 107 
The complexity of distinguishing spasticity from other positive symptoms highlights 108 
the challenges in developing suitable measurement systems. Firstly, a distinction has 109 
to be made between measurements that assess spasticity in a relaxed muscle or 110 
during activity. In most clinical settings, spasticity is measured using subjective, easy-111 
to-use ordinal scales that assess the level of resistance felt by the examiner during a 112 
passive muscle stretch. Examples of such scales include the Modified Ashworth 113 
Scale (MAS)8 and the Modified Tardieu Scale (MTS).9 The MTS is considered more 114 
valid for the assessment of spasticity as defined by Lance as the resistance is 115 
compared during stretches at different velocities. However, lack of standardization of 116 
stretch velocity and the subjective nature of both scales has resulted in poor inter-117 
rater reliability10,11and, for the MTS, inaccuracies in determining the correct catch 118 
angle.12 In light of the above mentioned difficulty of isolating spasticity, these tests 119 
also greatly oversimplify the phenomena. It is therefore not surprising that many 120 
studies have shown poor correlations between the clinical measures (MAS, MTS) 121 
and objective indicators of pathologically increased muscle activity during passive 122 
stretch.7,13–15 For example, some subjects, who have been found to have spasticity 123 
during a clinical examination as indicated by increased resistance to passive stretch, 124 
lacked any signs of hyperactive H-reflexes.16 In these cases, increased resistance to 125 
passive stretch may have been due to non-neural causes. 126 
 127 
Therefore, it is now acknowledged that quantified, instrumented methods should be 128 
used to provide a more accurate and valid evaluation of spasticity.17 In 2005, the 129 
state of the art on spasticity assessment was thoroughly summarized by the SPASM 130 
consortium into three review articles.18–20 These reviews identified and categorized a 131 
large number of non-invasive, instrumented applications for quantitative spasticity 132 
assessment into biomechanical and neurophysiological methods18,19, and concluded 133 
that both methods are complementary and should be used simultaneously to 134 
sufficiently differentiate between neural and non-neural causes of increased 135 
resistance.20 Biomechanical devices record joint-angular characteristics and/or 136 
resistance around a joint during passive stretching.18 They include for example 137 
motor-driven or hand-held dynamometers. Neurophysiological methods measure 138 
muscle activity using, for example, electromyography (EMG) during passive 139 
movement or nerve stimulation.19 Furthermore, the consortium stressed that 140 
collecting experimental data in a highly technical and controlled environment would 141 
greatly improve the modeling of the complex pathophysiology. However, combining 142 
these recommendations in view of a clinical application requires some compromise. 143 
A suitable method should on the one hand be more valid and reliable than the current 144 
clinical tests; and on the other hand, remain clinically feasible in different patient 145 
populations, including children. For example, whilst some motor-driven, isokinetic 146 
devices that measure limb resistance to passive movement have great reliability 147 
because the limb is moved at a controlled velocity,21–24 these are bulky and often 148 
difficult to apply to children in high-velocity stretches.20 In addition, a stretch reflex 149 
may be more easily elicited by a transient acceleration which is robotically more 150 
difficult to apply.25 A manually-controlled displacement method offers a clinically-151 
applicable alternative.26–28 However, to ensure accuracy, manually-controlled 152 
displacement methods must follow standardized protocols and the psychometric 153 
properties need to be defined before they can be used in clinical practice.20 A recent 154 
review of spasticity assessments for children and adolescents with CP highlighted 155 
insufficient psychometric soundness of spasticity evaluation tools.29 However, this 156 
review did not emphasize the need to integrate biomechanical and 157 
electrophysiological signals, as is recommended for valid spasticity assessment.20 158 
Therefore, their conclusion that electrophysiological methods to assess spasticity 159 
demonstrate the most promising results in terms of reliability and discriminate validity 160 
may have been misleading. 161 
 162 
The aim of the current study was two-fold. First, we wanted to systematically and 163 
critically assess clinically-applicable spasticity measurement methods that adhere to 164 
the recommendations of the SPASM consortium.20 Following these 165 
recommendations, any developed spasticity measurement method should (1) be able 166 
to make measurements at variable velocities of displacement; (2) incorporate 167 
simultaneous recording of EMG and torque; and (3) include a clearly defined 168 
protocol. To ensure a similar conceptualization of spasticity across reviewed articles 169 
(i.e. the definition of spasticity as offered by Lance4), only measurements during 170 
passive conditions were to be included. Secondly, we aimed to extract a set of 171 
quantitative parameters to measure spasticity based on the reviewed articles. 172 
 173 
 174 
METHODS 175 
 176 
Search Strategy 177 
A single reviewer (LB) performed a web-based search for relevant literature using the 178 
following electronic databases: Science Direct (www.sciencedirect.com), MEDLINE 179 
(PubMed) and Embase (www.embase.com). Only full-paper articles published in 180 
English in peer-reviewed journals, performed on human subjects, were included. 181 
Keywords included (‘All fields’ and MeSH): (1) spasticity; (2) tone; (3) cerebral palsy; 182 
(4) stroke; (5) spinal cord injury; (6) upper motor neuron; (7) measure; (8) evaluation; 183 
and (9) assessment. The following word combinations were implemented: 1 or 2; 184 
AND 3 or 4 or 5 or 6; AND 7 or 8 or 9. 185 
 186 
Study selection 187 
Two reviewers independently selected the studies for inclusion in the review. First, 188 
titles and abstracts were screened for eligibility. Second, the full text of potentially 189 
relevant papers was read to ascertain whether the study met all selection criteria, i.e.  190 
the article had to describe a method to quantitatively assess spasticity by recording 191 
both biomechanical and electrophysiological signals during manually-applied passive 192 
muscle stretches. Studies were excluded in case the method (1) only assessed 193 
spasticity based on subjective measurements, including Ashworth- and Tardieu-like 194 
scales11; (2) only applied a motor-controlled device or a pendulum-like test30 to 195 
stretch the muscle; (3) was limited to collecting either biomechanical or 196 
electrophysiological signals; (4) applied a passive stretch at only one velocity; or (5) 197 
assessed spasticity during function or active movements. Use of the tendon- and 198 
Hoffmann reflexes as a means to assess spasticity has been extensively studied,19 199 
however their clinical applicability and relevance is limited. Therefore, also studies 200 
applying excitation of these reflexes or electro stimulation as a neurophysiological 201 
means to assess spasticity were excluded from the current review. Finally, in those 202 
cases where more than one article was published by the same research group with 203 
the same methodology, the most recent publication was selected for review unless 204 
older articles investigated different psychometric properties. The bibliographic details 205 
of excluded studies were listed and reasons for exclusion noted. Any discrepancies 206 
regarding final selection were resolved by consensus and, if necessary, by consulting 207 
a third reviewer. 208 
 209 
Data extraction and quality assessment 210 
Selected studies were read by two independent reviewers (LB and KD) to extract 211 
information on study populations, methodology, study design, outcome parameters, 212 
results, and conclusions. Both reviewers independently evaluated the quality of the 213 
psychometric properties of the described method using the COSMIN checklist.31 The 214 
COSMIN checklist offers a common terminology and definitions of psychometric 215 
properties and consists of 12 domains.32 For each study included in the current 216 
review, only those domains relevant to the investigated psychometric properties were 217 
checked. The relevance of each domain and the interpretation with respect to 218 
spasticity measurements was discussed prior to commencing. Six domains were 219 
considered relevant (Table 1A in SuppInfo1): two were used to determine whether a 220 
study met the methodological quality on reliability and measurement error; two 221 
assessed the methods’ content and construct validity (including hypothesis testing); 222 
one assessed the responsiveness of the method; and finally, one determined the 223 
interpretability. Generalizability was determined for each of the previous domains. 224 
The following domains from the COSMIN checklist were not considered relevant for 225 
spasticity assessment: Item Response Theory (IRT), internal consistency, structural 226 
validity, cross-cultural validity and criterion validity. Reasons for not assessing these 227 
properties are described in Table 1B in SuppInfo1. 228 
 229 
Each of the six domains (and generalizability) were rated by both assessors 230 
independently on a 4-point scale according to the COSMIN guidelines.33 ‘Excellent’ 231 
quality was assigned if all relevant COSMIN items within a domain were scored as 232 
adequate. ‘Good’ quality was assigned to those studies that lacked some aspects, 233 
though it could still be assumed that the items were acceptable. ‘Fair’ quality was 234 
assigned if the measurement property was underrepresented, explored in a moderate 235 
sample size or when there were other minor flaws in the design or statistical 236 
analyses. ‘Poor’ quality was assigned if there were major flaws in the design or 237 
statistical analyses. Finally, in each article, the statistical findings per domain were 238 
rated according to quality criteria provided by Terwee et al. (2007) as positive, 239 
indeterminate, negative, or no information available (Table 1A in SuppInfo1).34 Per 240 
domain, all items, resulting scores and statistical ratings were then discussed by the 241 
reviewers and any discrepancies resolved by consensus. 242 
 243 
 244 
RESULTS 245 
 246 
A flow chart of the selection process can be viewed in Figure 1. After filtering the 247 
databases on keywords and screening titles and abstracts, 158 potential full-text 248 
articles were found. Further examination of these full-text articles revealed that 33 249 
papers did not apply an objective measurement method, 39 used a robot to displace 250 
the limb, 27 applied electrostimulation, and 38 articles measured either a 251 
biomechanical or an electrophysiological signal in isolation. One article measured 252 
both signals, but did not use the biomechanical parameters as a means to quantify 253 
spasticity. One article was excluded as the limb was only displaced at one velocity. 254 
Finally, three articles were excluded as their methodology was reported in more 255 
recent versions by the same research groups. Therefore, 15 studies were identified 256 
as meeting all the inclusion criteria. The data extracted from these are summarized in 257 
Tables 2-4 and in SuppInfo 2 and 3. A list of excluded full-text articles can be found 258 
in SuppInfo 4. 259 
 260 
Study populations and muscles tested 261 
Information on subjects, instrumentation and protocol details are summarized in 262 
Table 1. Seven of the 15 articles studied spasticity in adults post-stroke.35–41 Two 263 
articles included persons with spinal cord injury,42,43 and four reported on children 264 
with CP.27,44–46 One study included adults post-stroke and adults and children with 265 
CP in the subject group.7 One article included adults post-stroke, spinal cord injury 266 
and adults with CP.47 Eight studies additionally included a healthy control 267 
group.27,35,39–41,45–47 Six articles studied spasticity in upper limb muscles13,27,35,37–39, 268 
eight in lower limb muscles,40–47 and one in both upper and lower limb muscles.7 269 
 270 
Instruments and protocols  271 
Angular position/velocity was recorded in most studies using calibrated 272 
potentiometers or electrogoniometers7,13,27,35,37,39–44,47, in two studies using inertial 273 
sensors containing an accelerometer and a gyroscope45,46, and in one study, a 274 
velocity sensor was used.38 Forces and/or torques exerted at the joint when manually 275 
displacing the segment during passive stretch, were measured with different devices. 276 
Most often, force measurements were carried out using single or multiple-axes force 277 
transducers7,13,35,37,39–41,43–47 or differential pressure sensors.38 Forces were then 278 
recomputed to torques based on measurements39–41,44–47 or estimations38,43 of 279 
moment arms. Three studies directly measured torque near the joints42 in order to 280 
account for the torques applied by the examiner on the handle of the sensor.45,46 All 281 
studies used surface EMG (sEMG) to record agonist muscle activity and eight studies 282 
additionally measured the antagonist muscle activity. 283 
 284 
All studies assessed spasticity during passive ramp stretches of the spastic agonist 285 
muscles, except for three studies that analyzed passive sinusoidal movements35,38,39, 286 
and two studies that did both.40,41 Stretches were performed either at two velocities 287 
(slow and fast)7,13,37,39,41,43,45,46; at three velocities35,44; or at four or more 288 
velocities.27,38,40,42,47 Stretch velocities ranged from 2-720°/s. One study did not report 289 
the applied stretch velocity.44 Within each velocity, stretch repetitions were applied at 290 
zero to one minute intervals.  291 
In addition to instrumented spasticity tests, 12 of the 15 studies assessed spasticity 292 
with the (M)AS7,13,27,35,37,38,41,42,44–46 and two studies additionally used the (M)TS.44,46 293 
Three studies in adults post-stroke also examined the relation between spasticity 294 
indicators and upper limb function.35,37,39 295 
 296 
Study design and data analysis  297 
While most authors failed to mention how spasticity was defined in their study, the 298 
majority followed the reasoning that velocity-dependent hyperactivity of the stretch 299 
reflex causes a pathological augmentation in muscle activity.4 Slow stretching was 300 
performed at a velocity below the threshold of stretch reflex activity, whereby it was 301 
hypothesized that non-neural elastoviscous muscle properties accounted for any 302 
increased force or torque measured over the range of motion (ROM). During a high-303 
velocity passive stretch, activation of the muscle additionally influenced any increase 304 
in torque. The amount of gain in muscle activity, its timing and the amount of torque 305 
produced at different stretch velocities constituted some of the possible quantifiable 306 
measures of spasticity. A summary of the main outcome parameters developed by 307 
each study to quantify spasticity can be found in Table 2. In Table 2, a distinction is 308 
made between parameters that mostly reflect either angular position/velocity, forces 309 
and/or torques, or muscle activity. The velocity at which each parameter was 310 
examined is also specified. However, most studies combined different signals and 311 
velocities to develop their outcome parameters.  312 
 313 
For the angular position/velocity parameters, all, but two40,43, studies measured the 314 
available ROM during a passive stretch performed at a velocity below the threshold 315 
of stretch reflex activity. Therefore, any decreased ROM or catch angle27,46 during a 316 
higher velocity stretch was presumed to be caused by increased muscle activity. 317 
Often referred to as either resistance37,40,41,47 or stiffness27, the slope of the torque-318 
angle curve was the most common measure of increased torque. This parameter was 319 
calculated over the entire ROM13, or over a section of the ROM35,37,39–42,47 and 320 
compared between velocities13,27,35,37,40,47 or between positions.42 Four studies 321 
examined the torque value at a specific joint angle at different velocities.27,43,45,46, 322 
Four studies additionally examined the integral of the torque-position graphs to 323 
quantify the amount of work needed to stretch the examined muscle27,45–47 and one 324 
study calculated the integral of the torque-time graph.7 When stretches were 325 
performed against the force of gravity and the mass of the displaced segment was 326 
not negligible7,27,38,42,44–47, five studies subtracted the effect of inertia from the 327 
resulting measured torque.27,38,45–47 328 
 329 
Nine of the 15 articles quantified sEMG amplitude by calculating the average root 330 
mean square of the sEMG signal (RMS-EMG) over a particular 331 
interval,7,13,35,37,39,42,44–46, two by examining the gain in RMS-EMG over the ROM,40,41 332 
and one by calculating the maximum value of the RMS-EMG.47 Similarly to the 333 
biomechanical parameters, average RMS-EMG was often calculated over a specific 334 
portion of the ROM and compared between velocities. Two articles normalizing the 335 
RMS-EMG amplitude value to maximum isometric voluntary contraction.44,45 Three 336 
articles recorded and analyzed either the angle or the velocity at EMG onset.27,38,42 337 
Two articles identified different types of spasticity based on sEMG parameters.37,47 338 
 339 
Psychometric properties  340 
Reliability  341 
The COSMIN scores of those studies examining reliability can be found in Table 3. 342 
For an extended version of this table also containing the methodological and 343 
statistical results and scores the readers are referred to SuppInfo2. Six 344 
studies27,35,39,42,43,45 explored the intra-rater reliability of some, or all, outcome 345 
parameters from the instrumented tests and two studies13,46 referred to previously 346 
collected reliability results. Of these eight studies, only four examined the reliability of 347 
electrophysiological parameters in addition to biomechanical parameters in patient 348 
populations35,39,45,46 and two studies additionally assessed inter-rater reliability.35,39 349 
The methodological quality of studies ranged from poor to good as study samples 350 
tended to be small or the interval between repeated measurements was 351 
inappropriate. Reliability results were generally better among persons with disabilities 352 
than among control groups and biomechanical parameters tended to have higher 353 
relative reliability than electrophysiological parameters.35,39 Turk et al. reported on the 354 
measurement error of the parameters in their study, which ranged from 40-77% of 355 
the mean values of those parameters in their subject sample.39 Several parameters 356 
from the studies by Bar-On et al. were found to have an absolute measurement error 357 
small enough to distinguish between groups45 and detect change due to treatment.46 358 
The minimally important change (MIC) was not identified in any study. 359 
 360 
Validity 361 
The COSMIN scores on the validity of the different studies are summarized in Table 362 
4. The methodological quality of the included studies ranged from poor to excellent 363 
with the main weaknesses being uncertainty of statistical strength and limited 364 
analyses mainly for content validity. Reasons for score allocation per domain 365 
together with methodological and statistical scores can be found in SuppInfo3. 366 
 367 
Content validity 368 
Content validity was evaluated by a comparison of biomechanical to 369 
electrophysiological parameters,7,13,37,40,47 or by a comparison of parameters between 370 
stretch velocities.7,13,27,37,40–42,45–47 Pandyan et al.13 and Fleuren et al.7 reported 371 
conflicting results regarding the correlation between RMS-EMG and the slope of the 372 
torque-angle curve in spastic elbow flexors.7,13 On the hand, in the soleus of subjects 373 
post-stroke, higher torque values were associated with hyperactive stretch reflexes40 374 
and the gain in EMG accounted for 27% of the variance in the measured torque.41 375 
Associations between patterns of muscle activity and the biomechanical parameters 376 
during high velocity passive stretches could not be demonstrated in the wrist37 or the 377 
knee flexors.47 On the other hand, electrophysiological13,27,37,40,42,45,46 and 378 
biomechanical7,37,38,45,46 parameters often changed with increasing stretch velocity. 379 
Two studies reported no increase in the slope of the torque-angle curve between 380 
velocities.13,40 381 
 382 
Construct validity and hypothesis testing 383 
Evidence of the constructs or hypotheses were tested in 12 studies by either 384 
comparing persons with disabilities to a control group27,35,39–41,45,47, by comparison to 385 
a clinical spasticity test7,13,27,35,37,41,44–46 or by comparison to a motor-driven test.35,43 386 
In those studies comparing persons with disabilities to controls, average RMS-EMG 387 
parameters were always able to distinguish between groups.35,39,46,47 In contrast, only 388 
in four studies, and only in some muscles, were biomechanical parameters able to 389 
distinguish persons with disabilities from controls.27,40,45,47 Conflicting results were 390 
found when outcome parameters were related to the scores of clinical spasticity 391 
tests. Two studies reported good, significant correlations (r=0.64) between RMS-392 
EMG and MAS-scores for some muscles7,35 while others reported low associations 393 
(r=0.0613, k=0.0944). RMS-EMG parameters were significantly higher in hamstring 394 
muscles of children with CP with high MAS scores (2-3) than those with low MAS 395 
scores (1-1+), but this was not the case for the gastrocnemius.45 Similarly for the 396 
(M)TS, conflicting results were found for the calf muscles of children with CP with one 397 
study reporting good agreement (k=-0.48) between the angle of response as 398 
measured by the TS and RMS-EMG44 and another, only poor to fair (r=0.2) 399 
correlations.45 In five studies, ROM and biomechanical parameters were strongly 400 
correlated to MAS-scores7,27,35,41,45 and in one study to the TS.44 However, Malhotra 401 
et al.37 found that their biomechanical parameters did not increase with increasing 402 
MAS-scores. Bar-On et al. found that the instrumented assessment identified 403 
significantly more responders to treatment with Botulinum Toxin-A injections in the 404 
hamstrings than the MAS, but not more than the MTS. However, a combination of 405 
several baseline parameters from the instrumented test could better predict the effect 406 
of treatment than the baseline MTS alone.46 Parameters from a manual device were 407 
compared to those from a motor-driven device and showed very good correlations 408 
(r=0.86-0.94).35 On the other hand, Lamontagne et al. detected fewer subjects with 409 
hyperactive stretch reflexes using the motor-driven system than with the hand-held 410 
device although, in this study, stretch velocities were not comparable.43 411 
 412 
Responsiveness and interpretability 413 
Responsiveness to anti-spasticity medication was evaluated by only two studies. 414 
However, the conclusions of one study were weakened as the methodology did not 415 
fulfill all criteria for high quality.38 No study provided minimally important change 416 
values. In three studies,39,45,46 the smallest detectible change (SDC) values could be 417 
calculated from the reported absolute measurement errors. Bar-On et al. identified 418 
EMG and torque-related parameters that, relative to the SDC, decreased post-419 
treatment.46 No study investigated all aspects of content validity, construct validity 420 
and responsiveness as relevant to spasticity measurement. 421 
 422 
 423 
DISCUSSION 424 
 425 
The goal of this systematic review was to identify instrumented spasticity assessment 426 
methods that could be used as viable alternatives to the commonly-applied clinical 427 
evaluations such as the MAS. Fifteen instrumented spasticity assessment methods 428 
developed following the recommendations by the SPASM consortium20 were 429 
identified. These methods are manually-controlled, ensuring their ability to be 430 
translated to clinical settings, and measure both electrophysiological and 431 
biomechanical signals.  432 
 433 
In comparison to previous reviews17–20,29,30, the current paper covered a narrower 434 
scope of spasticity assessments by reporting on the measurement of passive-state 435 
spasticity only. This focus ensured that the concept of spasticity was similarly defined 436 
in all of the included studies, namely the definition of spasticity as offered by Lance.4 437 
A wider definition of spasticity includes spasticity as manifested during active 438 
conditions.5 The exact pathophysiology of spasticity during active motion remains 439 
debatable,48 and consequently, the literature related to its impact on function, 440 
divided.40,49 While in the passive state, enhanced muscle activity is primarily 441 
pathological, in the active state, it is more difficult to discern reflex-mediated activity 442 
from voluntary activation. In persons with an UMN syndrome, activation is also 443 
influenced by other phenomena such as sensory-motor control problems and 444 
weakness. It is therefore speculative whether one can apply a theory developed for 445 
measurement of a phenomenon in the passive state to the complex activation 446 
occurring during activity.50 While it is acknowledged that spasticity affects activity, we 447 
believe that accurate assessment methods need first to be developed for passive 448 
and active situations separately in order to decompose the multifactorial 449 
phenomenon. 450 
 451 
Overall, findings of the current review show that manually-controlled instrumented 452 
spasticity assessments that are clinically-applicable are available. Those developed 453 
for assessing spasticity in the hamstrings in children with spastic CP, have, so far, 454 
undergone the most rigorous clinical assessments.45,46 However, no developed 455 
method has been sufficiently assessed on all the required psychometric properties. 456 
Several UMN syndromes were assessed in the included studies showing that 457 
spasticity can be quantified in a variety of different pathologies. However, most 458 
literature on this subject has been carried out in adults post-stroke and the number of 459 
muscles investigated remain limited. This indicates that instrumented spasticity 460 
assessment in other areas still requires much development. Similar to the findings of 461 
Flamand et al.29, only six studies were identified studying spasticity in children with 462 
CP with information on absolute reliability and responsiveness limited to work by only 463 
one research group.45,46 464 
 465 
Most of the reliability findings were limited to biomechanical parameters with only four 466 
studies including a reliability analysis of RMS-EMG parameters among persons with 467 
disabilities.35,39,45,46 Since no or little electrophysiological response is expected when 468 
passively stretching healthy muscles, it was not surprising that relative reliability in 469 
control subjects was poor. However, also among patient populations, the 470 
electrophysiological response was occasionally found to be variable and unstable.39 471 
To reduce the variability inherent to RMS-EMG and to be able to compare between 472 
subjects, signals can be normalized to a maximum voluntary contraction as was done  473 
in two of the reviewed studies.44,45 However this normalization technique in persons 474 
with co-contraction and weakness is debatable.51 EMG can also be normalized to an 475 
M-wave during a supramaximal stimulation.52 However, more studies are required to 476 
assess the clinical applicability of such a method. As an essential start, better 477 
protocol standardization is required to reduce the variability of RMS-EMG 478 
parameters. On the other hand, the variability in response may also be a true 479 
phenomenon of spasticity. More reliability studies are required to investigate this.  480 
 481 
Quantification of the measurement error of an instrument is also an important part of 482 
reliability and responsiveness analyses. Calculation of the SEM was carried out in 483 
three of the reviewed studies.39,45,46 This permits the calculation of the SDC which is 484 
the value of the amount of change that falls outside the measurement error of an 485 
instrument.53 This is essential for a methods application as an evaluative measure in 486 
intervention studies and without it, clinical practice is limited. In Bar-On et al., three 487 
parameters were identified that, on average, decreased more than the SDC post-488 
treatment with Botulinum toxin-A. In addition, the baseline values of these 489 
parameters were able to predict the response post-treatment.46 The MIC refers to the 490 
change which is considered to be minimally important by patients and clinicians.53 491 
The MIC differs from the SDC as it cannot be statistically determined. Instead, it 492 
requires large, in-depth intervention studies often in combination with clinical 493 
consensus. Such methodology was not applied in any of the reviewed studies which 494 
resulted in limited scores on the interpretability item of the COSMIN checklist. 495 
 496 
To be clinically applicable, an assessment also needs to be compact and easy to 497 
administer. Although clinical feasibility and utility were not systematically assessed in 498 
the current review, the choice to only include manually-controlled assessment 499 
methods partially covered this issue. Especially in children, and particularly during 500 
high-velocity displacements, a motor-driven device may prevent the subject from 501 
being sufficiently relaxed. Manual assessments on the other hand are better 502 
tolerated, allow the examiner to have more control over the state of the subject and 503 
are transportable. In the study of Malhotra et al.37, for example, the assessments 504 
were performed at the patient’s bedside. 505 
 506 
The compromise between accessibility and accuracy is also challenged by the 507 
necessity to record and synchronize both electrophysiological and biomechanical 508 
signals. Fortunately, technological advancements have improved the accuracy, 509 
synchronization capabilities and portability of equipment. For example, wireless 510 
inertial measurement units are reliable and valid in motion analysis12 and are 511 
recently, being combined with EMG sensor technology.  512 
 513 
Recording kinematic data is essential for comprehensive spasticity assessment. First, 514 
it ensures the consistency of stretch performance and allows for interpretation of data 515 
in accordance to the velocity of stretch. Secondly, with advances in musculoskeletal 516 
modeling, kinematic data can be used to calculate muscle lengths and lengthening 517 
velocities,54 essential for spasticity interpretation. While all of the reviewed methods 518 
acknowledged the need to assess spasticity at various muscle lengthening velocities, 519 
only eight studies integrated the information from EMG and torque with velocity. Even 520 
fewer explored both signals relative to joint position or muscle length.37,42 Evaluating 521 
EMG response to both increasing muscle length and lengthening velocity allows 522 
identification of stretch reflex thresholds (SRTs) which in persons with an UMN 523 
syndrome, have been found to be reduced.55 Studies in adults suggest that 524 
decreased SRTs may be related to spasticity severity,56 type of motor deficit,55 and 525 
risk of developing contractures.37 Investigating both the dynamic and static SRTs in 526 
elbow flexors, Jobin and Levin found more velocity-dependence of the SRTs in 527 
children with CP compared to adults with stroke.57 Van der Salm et al.42 highlighted 528 
position-dependent activation in persons with SCI in which the joint angle, rather than 529 
the angular velocity, was the trigger of the neurological response. These findings 530 
were supported by two more studies that identified either position or velocity-531 
dependent muscle activation patterns among different subjects.37,47 Chen et al. 532 
reported an increase of the dynamic SRT post BTX-A treatment.38 However, 533 
identification of SRTs is highly dependent on the performance of controlled, yet 534 
variable stretch velocities which may be more difficult to achieve with manual 535 
stretches.58 Nevertheless, as protocols become more standardized, the reliability of 536 
acquiring these parameters with a manual test is worth further investigation. 537 
 538 
Several studies were able to show that measuring average RMS-EMG, either over 539 
the full ROM, over a specific interval or as a function of velocity, distinguished 540 
between persons with disabilities and controls.19,39,45,47 On the other hand, only three 541 
studies showed that some of the developed biomechanical parameters, namely the 542 
slope of the torque-velocity curve27 and the integral of the torque-angle curve45,47 543 
were higher in persons with disabilities than in controls. Results on content validity 544 
showed only moderate correlations between torque-angle curves and RMS-EMG.13 545 
Chen et al.38 found that the velocity-dependent viscous component calculated from 546 
the torque-velocity curve during a sinusoidal motion was sensitive to treatment with 547 
BTX-A. Interpreting these results together, it is possible that a parameter based on 548 
torque and velocity best corroborates the velocity-dependent nature of spasticity 549 
while the slope of the torque-angle curve is better used as a measure of non-neural 550 
related stiffness. The lack of agreement on which parameter best quantifies the 551 
biomechanical effect of spasticity may be solved by better differentiation of the neural 552 
and non-neural components of increased torque. Models that differentiate into 553 
components such as reflex-mediated torque, stiffness and viscosity have mostly been 554 
validated on data collected in research settings using motor-driven devices.24,59 555 
Proponents of motor-driven spasticity assessment devices, argue that by allowing a 556 
robot to control the displacement, the limb dynamics of the experimenter can be 557 
avoided allowing for accurate modeling of the persons passive state. Nevertheless, 558 
as was partially shown by two of the included studies, by improving the performance 559 
standardization of manual-tests, a distinction can be made between an increase in 560 
torque which is aggregated by muscle activity or an increase in torque of non-neural 561 
origin, e.g. contracture.37,47 Future work should focus on validating the different 562 
components and checking their responsiveness to treatment. 563 
 564 
Although comparison of an instrumented test to a clinical comparator was indicated in 565 
the current review as comprising a part of construct validity, multiple studies have 566 
shown the inadequacy of clinical tests such as the (M)AS and (M)TS in assessing 567 
spasticity.10,11,45,60,61 Therefore, it was not surprising that in general, the articles 568 
reviewed reported poor correlations between the electrophysiological findings of the 569 
instrumented tests and the scores of the (M)AS and (M)TS. This finding confirms the 570 
inadequacy of the clinical tests rather than highlighting the construct validity of the 571 
instrumented alternatives. The (M)AS and (M)TS may be useful for diagnostic and 572 
broad screening purposes for distinguishing spastic from healthy muscles and for 573 
categorizing muscles into broad severity categories.45,62 However, for a 574 
comprehensive picture of the problem and better differentiation of mid-range 575 
severities, the clinical exams should be supported by more rigorous, instrumented 576 
assessments, especially for persons undergoing treatment.46 577 
 578 
In conclusion, the search for a clinically-applicable, instrumented spasticity 579 
assessment is still ongoing as the translational capabilities from research to clinic are 580 
unnecessarily lagging behind. Some promising developments of instrumented 581 
spasticity assessments that integrate signals have been found. However, more 582 
consensus is required on the optimal parameters that quantify spasticity, provide 583 
insight on its nature and differentiate it from non-neural related increases in torque. 584 
Parameters based on RMS-EMG fulfill aspects of validity in adults post-stroke13,37 585 
and in children with CP.27,45 However, the inter-rater reliability of these parameters 586 
remains unexplored and responsiveness studies should be expanded to more 587 
muscles and different patient populations. Most importantly, for a parameter based 588 
on RMS-EMG to be used as a quantifiable measure of spasticity, methods should 589 
aim at standardizing their tests to ensure adequate reproducibility. Few developed 590 
torque-related parameters possess convincing content or construct validity to be 591 
used as clinical measures of spasticity. However, by improving the joint torque 592 
models and differentiating the components of increased torque, this could be 593 
achieved. Simple, but accurate applications of an instrumented spasticity assessment 594 
will greatly advance clinical practice in terms of treatment planning and outcome 595 
evaluation. In parallel, collection of instrumented data will help define and classify 596 
different aspects of spasticity providing insight into the many paradigms related to its 597 
pathophysiology. 598 
 599 
 600 
REFERENCES 601 
1.  Morrell DS, Pearson JM, Sauser DD. Progressive Bone and Joint 602 
Abnormalities of the Spine and Lower Extremities in Cerebral Palsy. 603 
Radiographics 2002; 22: 257–68.  604 
2.  Malhotra S, Pandyan A, Day CR, Jones PW, Hermens H. Spasticity, an 605 
impairment that is poorly defined and poorly measured. Clin Rehabil 2009; 23: 606 
651–8.  607 
3.  Tardieu G, Shentoub S, Delarue R. A la recherche d’une technique de mesure 608 
de la spasticite imprime avec le periodique. Neurologique 1954; 91: 143–4.  609 
4.  Lance JW. The control of muscle tone, reflexes, and movement: Robert 610 
Wartenbeg Lecture. Neurology 1980; 30: 1303.  611 
5.  Pandyan A, Gregoric M, Barnes M, Wood D, Wijck F Van, Burridge J, et al. 612 
Spasticity: Clinical perceptions, neurological realities and meaningful 613 
measurement. Disabil Rehabil 2005; 27: 2–6.  614 
6.  Sanger TD, Delgado MR, Gaebler-Spira D, Hallett M, Mink JW. Classification 615 
and definition of disorders causing hypertonia in childhood. Pediatrics 2003; 616 
111: e89–e97.  617 
7.  Fleuren JFM, Voerman GE, Erren-Wolters C V, Snoek GJ, Rietman JS, 618 
Hermens HJ, et al. Stop using the Ashworth Scale for the assessment of 619 
spasticity. J Neurol Neurosurg Psychiatry 2010; 81: 46–52.  620 
8.  Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of 621 
muscle spasticity. Phys Ther 1987; 67: 206–7.  622 
9.  Boyd RN, Graham HK. Objective measurement of clinical findings in the use of 623 
botulinum toxin type A for the management of children with cerebral palsy. Eur 624 
J Neurol 1999; 6: 23–35.  625 
10.  Haugh AB, Pandyan AD, Johnson GR. A systematic review of the Tardieu 626 
Scale for the measurement of spasticity. Disabil Rehabil 2006; 28: 899–907.  627 
11.  Platz T, Eickhof C, Nuyens G, Vuadens P. Clinical scales for the assessment of 628 
spasticity, associated phenomena, and function: a systematic review of the 629 
literature. Disabil Rehabil 2005; 27: 7–18.  630 
12.  Van den Noort JC, Scholtes VA, Harlaar J. Evaluation of clinical spasticity 631 
assessment in cerebral palsy using inertial sensors. Gait Posture 2009; 30: 632 
138–43.  633 
13.  Pandyan AD, Van Wijck FMJ, Stark S, Vuadens P, Johnson GR, Barnes MP. 634 
The construct validity of a spasticity measurement device for clinical practice: 635 
an alternative to the Ashworth scales. Disabil Rehabil 2006; 28: 579–85.  636 
14.  Lebiedowska MK, Fisk JR. Passive dynamics of the knee joint in healthy 637 
children and children affected by spastic paresis. Clin Biomech 1999; 14: 653–638 
60.  639 
15.  Bar-On L, Aertbeliën E, Molenaers G, Bruyninckx H, Monari D, Jaspers E, et al. 640 
Comprehensive quantification of the spastic catch in children with cerebral 641 
palsy. Res Dev Disabil 2012; 34: 386–96.  642 
16.  Shindler-Ivens S, Shields R. Soleus H-reflex recruitment is not altered in 643 
persons with chronic spinal cord injury. Arch Phys Med Rehabil 2004; 85: 840–644 
7.  645 
17.  Biering-Sørensen F, Nielsen JB, Klinge K. Spasticity-assessment: a review. 646 
Spinal Cord 2006; 44: 708–22.  647 
18.  Wood D, Burridge J, Van Wijck F, McFadden C, Hitchcock R, Pandyan A, et al. 648 
Biomechanical approaches applied to the lower and upper limb for the 649 
measurement of spasticity: A systematic review of the literature. Disabil 650 
Rehabil 2005; 27: 19–33.  651 
19.  Voerman G, Gregorič M, Hermens H. Neurophysiological methods for the 652 
assessment of spasticity: The Hoffmann reflex, the tendon reflex, and the 653 
stretch reflex. Disabil Rehabil 2005; 27: 33–68.  654 
20.  Burridge J, Wood D, Hermens H, Voerman G, Johnson G, Van Wijck F, et al. 655 
Theoretical and methodological considerations in the measurement of 656 
spasticity. Disabil Rehabil 2005; 27: 69–80.  657 
21.  Sinkjaer T, Magnussen I. Passive, intrinsic and reflex-mediated stiffness in the 658 
ankle extensors of hemiparetic patients. Brain 1994; 117: 355–63.  659 
22.  Mirbagheri MM, Barbeau H, Ladouceur M, Kearney RE. Intrinsic and reflex 660 
stiffness in normal and spastic, spinal cord injured subjects. Exp Brain Res 661 
2001; 141: 446–59.  662 
23.  Chung SG, van Rey E, Bai Z, Rymer WZ, Roth EJ, Zhang L-Q. Separate 663 
quantification of reflex and nonreflex components of spastic hypertonia in 664 
chronic hemiparesis. Arch Phys Med Rehabil 2008; 89: 700–10.  665 
24.  De Vlugt E, de Groot JH, Schenkeveld KE, Arendzen JH, van der Helm FCT, 666 
Meskers CGM. The relation between neuromechanical parameters and 667 
Ashworth score in stroke patients. J Neuroeng Rehabil 2010; 7: 35.  668 
25.  Rabita G, Dupont L, Thevenon A, Lensel-Corbeil G, Pérot C, Vanvelcenaher J. 669 
Differences in kinematic parameters and plantarflexor reflex responses 670 
between manual (Ashworth) and isokinetic mobilisations in spasticity 671 
assessment. Clin Neurophysiol 2005; 116: 93–100.  672 
26.  Lee H-M, Chen J-JJ, Ju M-S, Lin C-CK, Poon PPW. Validation of portable 673 
muscle tone measurement device for quantifying velocity-dependent properties 674 
in elbow spasticity. J Electromyogr Kinesiol 2004; 14: 577–89.  675 
27.  Wu Y-N, Ren Y, Goldsmith A, Gaebler D, Liu SQ, Zhang L-Q. Characterization 676 
of spasticity in cerebral palsy: dependence of catch angle on velocity. Dev Med 677 
Child Neurol 2010; 52: 563–9.  678 
28.  Bénard MR, Jaspers RT, Huijing PA, Becher JG, Harlaar J. Reproducibility of 679 
hand-held ankle dynamometry to measure altered ankle moment-angle 680 
characteristics in children with spastic cerebral palsy. Clin Biomech; 2010; 25: 681 
802–8.  682 
29.  Flamand VH, Massé-Alarie H, Schneider C. Psychometric evidence of 683 
spasticity measurement tools in cerebral palsy children and adolescents: a 684 
systematic review. J Rehabil Med 2013; 45: 14–23.  685 
30.  Johnson GR. Outcome measures of spasticity. Eur J Neurol 2002; 9 Suppl 1: 686 
10–6.  687 
31.  Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. 688 
The COSMIN checklist for assessing the methodological quality of studies on 689 
measurement properties of health status measurement instruments: an 690 
international Delphi study. Qual Life Res 2010; 19: 539–49.  691 
32.  Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. 692 
The COSMIN study reached international consensus on taxonomy, 693 
terminology, and definitions of measurement properties for health-related 694 
patient-reported outcomes. J Clin Epidemiol; 2010; 63: 737–45.  695 
33.  Terwee CB, Mokkink LB, Knol DL, Ostelo RWJG, Bouter LM, de Vet HCW. 696 
Rating the methodological quality in systematic reviews of studies on 697 
measurement properties: a scoring system for the COSMIN checklist. Qual Life 698 
Res 2012; 21: 651–7.  699 
34.  Terwee CB, Bot SDM, de Boer MR, van der Windt DAWM, Knol DL, Dekker J, 700 
et al. Quality criteria were proposed for measurement properties of health 701 
status questionnaires. J Clin Epidemiol 2007; 60: 34–42.  702 
35.  Voerman GE, Burridge JH, Hitchcock R a, Hermens HJ. Clinometric properties 703 
of a clinical spasticity measurement tool. Disabil Rehabil 2007; 29: 1870–80.  704 
36.  Pandyan AD, Vuadens P, van Wijck FM, Stark S, Johnson GR, Barnes MP. 705 
Are we underestimating the clinical efficacy of botulinum toxin (type A)? 706 
Quantifying changes in spasticity, strength and upper limb function after 707 
injections of Botox to the elbow flexors in a unilateral stroke population. Clin 708 
Rehabil 2002; 16: 654–60.  709 
37.  Malhotra S, Cousins E, Ward A, Day C, Jones P, Roffe C, et al. An 710 
investigation into the agreement between clinical, biomechanical and 711 
neurophysiological measures of spasticity. Clin Rehabil 2008; 22: 1105–15.  712 
38.  Chen J-JJ, Wu Y-N, Huang S-C, Lee H-M, Wang Y-L. The use of a portable 713 
muscle tone measurement device to measure the effects of botulinum toxin 714 
type a on elbow flexor spasticity. Arch Phys Med Rehabil 2005; 86: 1655–60.  715 
39.  Turk R, Notley SV, Pickering RM, Simpson DM, Wright PA, Burridge JH. 716 
Reliability and sensitivity of a wrist rig to measure motor control and spasticity 717 
in poststroke hemiplegia. Neurorehabil Neural Repair 2008; 22: 684–96.  718 
40.  Ada L, Vattanasilp W, O’Dwyer NJ, Crosbie J. Does spasticity contribute to 719 
walking dysfunction after stroke? J Neurol Neurosurg Psychiatry 1998; 64: 720 
628–35.  721 
41.  Vattanasilp W, Ada L, Crosbie J. Contribution of thixotropy, spasticity, and 722 
contracture to ankle stiffness after stroke. J Neurol Neurosurg Psychiatry 2000; 723 
69: 34–9.  724 
42.  Van der Salm A, Veltink PH, Hermens HJ, Ijzerman MJ, Nene AV. 725 
Development of a new method for objective assessment of spasticity using full 726 
range passive movements. Arch Phys Med Rehabil 2005; 86: 1991–7.  727 
43.  Lamontagne A, Malouin F, Richards CL, Dumas F. Evaluation of reflex- and 728 
nonreflex-induced muscle resistance to stretch in adults with spinal cord injury 729 
using hand-held and isokinetic dynamometry. Phys Ther 1998; 78: 964–78.  730 
44.  Alhusaini AA, Dean CM, Crosbie J, Shepherd RB, Lewis J. Evaluation of 731 
spasticity in children with cerebral palsy using Ashworth and Tardieu Scales 732 
compared with laboratory measures. J Child Neurol 2010; 25: 1242–7.  733 
45.  Bar-On L, Aertbeliën E, Wambacq H, Severijns D, Lambrecht K, Dan B, et al. A 734 
clinical measurement to quantify spasticity in children with cerebral palsy by 735 
integration of multidimensional signals. Gait Posture 2012; 38: 141–7.  736 
46.  Bar-On L, Van Campenhout A, Desloovere K, Aertbeliën E, Huenaerts C, 737 
Vandendoorent B, et al. Is an instrumented spasticity assessment an 738 
improvement over clinical spasticity scales in assessing and predicting the 739 
response to integrated Botulinum Toxin-A treatment in children with Cerebral 740 
Palsy? Arch Phys Med Rehabil; 2013; doi: 10.10.  741 
47.  Lebiedowska MK, Fisk JR. Knee resistance during passive stretch in patients 742 
with hypertonia. J Neurosci Methods 2009; 179: 323–30.  743 
48.  Thilmann AF, Fellows SJ, Garms E. The mechanism of spastic muscle 744 
hypertonus. Variation in reflex gain over the time course of spasticity. Brain 745 
1991; 114: 233–44.  746 
49.  Nielsen JB, Petersen NT, Crone C, Sinkjaer T. Stretch reflex regulation in 747 
healthy subjects and patients with spasticity. Neuromodulation 2005; 8: 49–57.  748 
50.  Dietz V, Sinkjaer T. Spastic movement disorder: impaired reflex function and 749 
altered muscle mechanics. Lancet Neurol 2007; 6: 725–33.  750 
51.  Phadke CP, Ismail F, Boulias C. Assessing the neurophysiological effects of 751 
botulinum toxin treatment for adults with focal limb spasticity: a systematic 752 
review. Disabil Rehabil 2012; 34: 91–100.  753 
52.  Willerslev-Olsen M, Lorentzen, Nielsen JB, Sinkjaer T. Passive muscle 754 
properties are altered in children with cerebral palsy before the age of 3 years 755 
and are difficult to distinguish clinically from spasticity. Dev Med Child Neurol 756 
2013; 55: 617–23.  757 
53.  De Vet HC, Terwee CB, Ostelo RW, Beckerman H, Knol DL, Bouter LM. 758 
Minimal changes in health status questionnaires: distinction between minimally 759 
detectable change and minimally important change. Health Qual Life Outcomes 760 
2006; 4: 54.  761 
54.  Delp SL, Anderson FC, Arnold AS, Loan P, Habib A, John CT, et al. OpenSim: 762 
open-source software to create and analyze dynamic simulations of movement. 763 
IEEE Trans Biomed Eng 2007; 54: 1940–50.  764 
55.  Levin MF, Feldman AG. The role of stretch reflex threshold regulation in normal 765 
and impaired motor control. Brain Res 1994; 657: 23–30.  766 
56.  Musampa NK, Mathieu PA, Levin MF. Relationship between stretch reflex 767 
thresholds and voluntary arm muscle activation in patients with spasticity. Exp 768 
brain Res 2007; 181: 579–93.  769 
57.  Jobin A, Levin MF. Regulation of stretch reflex threshold in elbow flexors in 770 
children with cerebral palsy: a new measure of spasticity. Dev Med Child 771 
Neurol 2000; 42: 531–40.  772 
58.  Calota A, Feldman AG, Levin MF. Spasticity measurement based on tonic 773 
stretch reflex threshold in stroke using a portable device. Clin Neurophysiol 774 
2008; 119: 2329–37.  775 
59.  Alibiglou L, Rymer WZ, Harvey RL, Mirbagheri MM. The relation between 776 
Ashworth scores and neuromechanical measurements of spasticity following 777 
stroke. J Neuroeng Rehabil 2008; 5: 18.  778 
60.  Yam WKL, Leung MSM. Interrater Reliability of Modified Ashworth Scale and 779 
Modified Tardieu Scale in Children With Spastic Cerebral Palsy. J Child Neurol 780 
2006; 21: 1031–5.  781 
61.  Pandyan AD, Johnson GR, Price CIM, Curless RH, Barnes MP, Rodgers H. A 782 
review of the properties and limitations of the Ashworth and modified Ashworth 783 
Scales as measures of spasticity. Clin Rehabil 1999; 13: 373–83.  784 
62.  Condliffe EG, Clark DJ, Patten C. Reliability of elbow stretch reflex assessment 785 
in chronic post-stroke hemiparesis. Clin Neurophysiol 2005; 116: 1870–8.  786 
63.  Staude G, Wolf W. Objective motor response onset detection in surface 787 
myoelectric signals. Med Eng Phys 1999; 21: 449–67.  788 
64.  Pandyan AD, Price CI, Rodgers H, Barnes MP, Johnson GR. Biomechanical 789 
examination of a commonly used measure of spasticity. Clin Biomech 2001; 790 
16: 859–65.  791 
 792 
Figure Legend 793 
Figure 1. Flow chart of article search and selection strategy. *References refer to the 794 
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Table 1 Characteristics of included studies: study populations and protocol design 
 Study population Protocol design 
First author Subjects N Age in 
years 
Diagnostic 
details 
Functional 
level 
Main Selection 
Criteria 
Agonists 
tested for 
spasticity 
Antagonists Instruments Type and 
trajectory of 
stretch  
Stretch 
velocities 
Number 
of reps 
per 
velocity 
Rest 
period 
between 
reps 
Comparator 
tests 
Lamontagne 
199843 
SCI 9 Mean 41 
SD 11 
1-5 years 
post injury; 
complete 
(n=8); 
incomplete 
(n=2); 
traumatic 
(n=8); 
ischemic 
(n=1) 
C6 (n=1); T5-
T6 (n=1); T5 
(n=3); T7 
(n=1); T8 
(n=1); T10 
(n=2) 
MAS score ≥1; 
no fixed 
contractures or 
deformities in 
lower limbs; no 
history of 
fracture or 
thrombophlebitis 
Soleus Tibialis 
anterior 
Hand-held 
dynamometer; 
electrogoniom
eter and 
potentiometer; 
sEMG; 
metronome 
Ramp 
movement 
from -35° 
plantarflexion 
to 5° 
dorsiflexion 
Low velocity 
average: 3.3 
SD 3.4°/s; 
high velocity 
average: 
311.1 SD 
380°/s 
5 1 sec Kin-Kom 
isokinetic 
dynamomet
er 
Wu 201027 CP 10 Mean: 10 
SD 3 
1 
quadriplegia; 
6 RH; 3 LH 
Movement 
disorder 
(spasticity, 
dystonia, 
ataxia) not 
mentioned 
GMFCS: I 
(n=2); II (n=3); 
III (n=2); IV 
(n=2); V (n=1) 
MACS: II 
(n=5); III 
(n=4); V (n=1) 
Not mentioned Bicpes 
brachii  
Tricpes 
brachii 
Torque 
sensor, 
potentiometer, 
sEMG  
Ramp 
movement 
from full elbow 
flexion to full 
elbow 
extension 
30, 90,180, 
270°/s 
1 at 
30°/s, 3 
at 90°/s, 
180°/s, 
and 
270°/s 
1 min MAS 
 TD 10 Mean: 10 
SD 3 
NR NR 
Voerman 
200735 
Stroke 12 Mean: 57 
SD 9 
First stroke, 9 
LH; 3 RH 
ARAT: 
(scored for 6 
subjects) 0 
(n=3); 2 (n=1); 
5 (n=1); 6 
(n=1) 
AS 1-3 in wrist 
and finger 
flexors, >20º 
pain-free wrist 
extension, 5º 
active wrist 
flexion, able to 
communicate, 
no history of 
serious medical, 
psychological or 
cognitive 
impairment 
Wrist 
flexors 
Wrist 
extensors 
Hand-held 
dynamometer, 
potentiometer, 
sEMG, 
electronic 
metronome  
Sinusoidal 
wrist 
movement 
from neutral to 
extension and 
back to 
neutral 
30, 60, 90 
cycles/min 
(180, 360, 
540°/s) 
5-7 None MAS; 
ARAT; wrist 
rig 
 Healthy 
subjects 
11 Mean: 57 
SD 8 
NR NR Not mentioned 
 Study population Protocol design 
First author Subjects N Age in 
years 
Diagnostic 
details 
Functional 
level 
Main Selection 
Criteria 
Agonists 
tested for 
spasticity 
Antagonists Instruments Type and 
trajectory of 
stretch  
Stretch 
velocities 
Number 
of reps 
per 
velocity 
Rest 
period 
between 
reps 
Comparator 
tests 
Van der Salm 
200542 
SCI 9 Mean: 35 
SD 7 
Minimum 6 
months after 
injury 
C5 (n=1); C6 
(n=2); C6-7 
(n=1); T4 
(n=1); T5 
(n=1); T4-5 
(n=1); T8 
(n=1); T11 
(n=1) 
MAS ≥1, >18 
years, absence 
of voluntary 
movements in 
triceps surae, 
tibialis anterior 
can contract 
using electrical 
stimulation, no 
fixed ankle 
contracture 
Triceps 
surae 
none Calibrated 
strain gauge 
dynanometer, 
potentiometer, 
gyroscope, 
sEMG 
Ramp 
movement 
across full 
ankle ROM  
Random 
between 30-
150°/s 
30-40 5 sec MAS 
Bar-On 
201245 
CP 28 Mean 10 
SD 5 
Spastic CP; 3 
RH; 5 LH; 19 
diplegia; 1 
quadriplegia 
GMFCS: I 
(n=10); II 
(n=12); III 
(n=5); IV 
(n=1) 
Age 5-18; 
spastic CP; no 
ankle or knee 
contractures, no 
previous 
orthopedic 
surgery, no 
intrathecal 
baclofen pump; 
no SDR; no 
BTX in last 6 
months 
Medial 
gastrocne
mius; 
medial 
hamstring
s 
Tibialis 
anterior; 
rectus 
femoris 
Torque/force 
load-cell; 
inertial 
measurement 
units, sEMG 
Ramp 
movement 
across full 
ankle or knee 
ROM 
Average low 
velocity: Gas. 
22.5 SD 
7.2°/s; Hams. 
35.2 SD 
7.5°/s; 
Average high 
velocity: Gas. 
202.1 SD 
54.2°/s; 
Hams. 317.7 
SD 47.7°/s 
4 7 sec MAS 
 TD 10 Mean 11 
SD 6 
NR NR Not mentioned 
Bar-On 
201346 
CP 31 Mean 9 
SD 2 
Spastic CP; 6 
RH; 5 LH; 17 
diplegia, 1 
triplegia; 2 
quadriplegia 
GMFCS: I 
(n=12); II 
(n=12); III 
(n=6); IV 
(n=1) 
Age 3-18; 
spastic CP; no 
ankle or knee 
contractures, no 
previous 
orthopedic 
surgery, no 
intrathecal 
baclofen pump; 
no SDR 
Medial 
hamstring
s 
Rectus 
femoris 
Torque/force 
load-cell; 
inertial 
measurement 
units, sEMG 
Ramp 
movement 
across full 
knee ROM 
Average low 
velocity: 
75.48 SD 
17.31°/s; 
average high 
velocity: 
288.44 SD 
54.11°/s 
4 7 sec MAS; MTS 
Pandyan 
200613 
Stroke 14 Median: 
61 IQR 
52-63 
Median 48 
months post  
stroke (IQR 
32-60), 6 LH; 
8 RH 
Not 
mentioned 
Clinical 
diagnosis of 
spasticity, 
capable of 
providing 
written, 
informed 
consent 
Bicpes 
brachii  
Triceps 
brachii 
Force 
tranducer, 
electrogonio-
meter, sEMG 
Ramp 
movement 
across full 
elbow ROM 
with humerus 
abducted to 
90° 
Slow, fast 
(median 
difference: 
34˚/s IQR 20-
46˚/s) 
1 slow 
stretch, 
1 fast 
stretch 
Not 
mention
ed 
MAS 
 Study population Protocol design 
First author Subjects N Age in 
years 
Diagnostic 
details 
Functional 
level 
Main Selection 
Criteria 
Agonists 
tested for 
spasticity 
Antagonists Instruments Type and 
trajectory of 
stretch  
Stretch 
velocities 
Number 
of reps 
per 
velocity 
Rest 
period 
between 
reps 
Comparator 
tests 
Lebiedowska 
200947  
Stroke  3 Mean: 65 
SD 8 
Not 
mentioned 
Not 
mentioned 
Not mentioned Medial 
hamstring
s, Rectus 
femoris 
Rectus 
femoris, 
Medial 
hamstrings 
Hand-held 
stain gauge 
dynanonmeter, 
potentiometer, 
sEMG 
Ramp 
movement 
from neutral to 
knee 
extension and 
from neutral to 
142˚ knee 
flexion 
0.2-1.5 rad/s 
(11.5-540˚/s) 
Several 
(not 
reported 
in detail) 
Not 
mention
ed 
none 
 Adults 
with CP 
4 35 SD 12 3 diplegia; 1 
RH 
 Children 
with CP 
13 13 SD 4 10 diplegia; 2 
RH; 1 LH 
 Healthy 
subjects 
19 13 SD 8  
Fleuren 20107  Stroke  18 Mean: 57 
SD 13-16 
Not 
mentioned 
Not 
mentioned 
Self-reported 
spasticity, no 
contractures, no 
severe pain, 
able to 
understand 
simple 
commands 
Biceps 
brachii, 
Brachio-
radialis, 
Rectus 
femoris, 
Vastus 
lateralis 
none Hand-held 
dynanometer, 
electrogonio-
meter, sEMG 
Ramp 
movement 
across full 
elbow and 
knee ROM 
(patient 
sidelying)  
Slow, fast 
(median 
velocity: 
76.6˚/s for 
elbow flexors, 
85.2˚/s for 
knee 
extensors) 
1 at slow 
velocity, 
2 at fast 
velocity 
Not 
mention
ed 
AS 
 CP  1 
 SCI  2 
 NMD 4 
Malhotra 
200837 
Stroke  10
0 
Median 74 
IQR 43-91 
Average of 3 
weeks post 
first stroke 
(range 1-6) 
52 RH; 48 LH 
ARAT: 0 
(n=97); 1 
(n=2); 3 (n=1) 
Within 6 weeks 
of first stroke, 
score of 0 on 
grasp section of 
ARAT, no wrist 
contractures, no 
major illness 
Long wrist 
flexors  
Long wrist 
extensors 
Force 
tranducer, 
electrogonio-
meter, sEMG 
Ramp 
movement 
across full 
wrist ROM 
Slow, fast 
(mean 
difference 
between 
velocities: 
87˚/s, SD 
36˚/s, range 
10-190˚/s)  
1 at 
each 
velocity 
NR MAS, 
ARAT, BI 
Chen 200538 Stroke 10 Mean: 57 
SD 12 
Average if 
38±27 
months post 
stroke, 3 RH; 
7 LH 
BI: III (n=4); IV 
(n=2); V (n=4) 
At least 6 
months post 
stroke, no elbow 
contractures, no 
severe cognitive 
or affective 
dysfunction, BI≥ 
III 
Biceps 
brachii 
Triceps 
brachii 
Air bags, 
differential 
pressure 
sensor, 
angular 
velocity 
sensor, sEMG 
Sinusoidal 
movement 
from 120˚ to 
60˚ elbow 
flexion 
1/3, 1/2, 1, 
1.5 Hz (120, 
180, 360, 
540˚/s) 
Not 
mention
ed 
≥30 sec MAS 
Turk 200839 Stroke 12 Mean: 62 
SD 12 
6±4 years 
post stroke, 4 
RH; 8 LH 
Mean ARAT: 
18.8±11.5 
At least 3 
months post 
stroke, some 
active wrist 
movement, no 
wrist 
contractures, no 
neglect or major 
illness 
Flexor 
carpi 
ulnaris, 
Flexor 
carpi 
radialis 
Extensor 
carpi 
radialis 
longus 
Strain gauges 
(force sensor), 
potentiometer, 
sEMG 
Sinusoidal 
movement 
across full 
wrist ROM 
Slow: 0.04 or 
0.08Hz (14.4 
or 28.8˚/s) 
Fast: 1.5Hz 
(540˚/s) 
2 at slow 
velocity 
followed 
by fast 
sinusoid
al 
Not 
mentione
d 
MAS, ARAT 
 Healthy 
adults 
12 51 SD 20 NR NR Not mentioned 
 Study population Protocol design 
First author Subjects N Age in 
years 
Diagnostic 
details 
Functional 
level 
Main Selection 
Criteria 
Agonists 
tested for 
spasticity 
Antagonists Instruments Type and 
trajectory of 
stretch  
Stretch 
velocities 
Number 
of reps 
per 
velocity 
Rest 
period 
between 
reps 
Comparator 
tests 
Alhusaini 
201044  
CP  27 Mean: 7 
SD 2 
Not 
mentioned 
GMFCS I and 
II 
Spastic CP, 
GMFCS I-II, no 
severe cognitive 
dysfunction, no 
orthopedic 
surgery, or anti-
spasticity 
treatment in 
previous 5 
months 
Medial 
gastrocne
mius, 
Soleus  
Tiabialis 
anterior 
Load cell, 
potentiometer, 
sEMG 
Ramp 
movement 
across full 
ROM  
As slow as 
possible, 
Slow, Fast 
At least 
3 
Not 
mention
ed 
MAS, TS 
Ada 199840 Stroke 14 Mean 65 
SD 9 
Hemiparetic; 
5-10 months 
post stroke 
≥3 on motor 
assessment 
scale 
≥3 on motor 
assessment 
scale; sufficient 
cognitive ability 
Medial 
gastrocne
mius 
None Load cell, 
potentiometer, 
sEMG 
Sinusoidal 
between 10° 
plantarflexion 
and 10° 
dorsiflexion 
0.5, 1, 1.5, 
2Hz (180, 
360, 540, 
720°/s) 
Each 
velocity 
trial was 
perform
ed 
during 
25 sec 
None None 
 Healthy 15  Mean 52 
SD 6 
NR NR Neurologically 
normal 
     
Vattanaslip 
201241 
Stroke 30 Mean 68 
SD 9 
2-5 years 
post stroke, 
12 RH, 18 LH 
Not 
mentioned 
Calf muscles 
diagnosed as 
clinically stiff, ≥2 
AS, sufficient 
cognitive ability, 
no other 
problems 
interfering with 
ankle motion 
Medial 
gastrocne
mius 
none Load cell, 
potentiometer, 
sEMG 
Ramp 
movement 
across full 
ROM; 
Sinusoidal 
between 10° 
plantarflexion 
and 10° 
dorsiflexion 
Undefined 
velocity for 
assessing 
contracture, 
2°/s for 
assessing 
thixotropy, 
and at 2Hz 
(720°/s) for 
assessing 
spasticity 
1 at 
undefine
d 
velocity; 
2 at 2°/s 
and 
during 
30 sec 
at 2Hz 
(720°/s) 
None AS 
 Healthy 
subjects 
10 Mean 59 
SD 8 
NR NR Not mentioned 
Reps, repetitions; CP, cerebral palsy; TD, typically developing; SCI, spinal cord injury; NMD, neuromuscular disease; RH, right hemiplegia; LH, left hemiplegia; IQR, Inter quartile range; reps., 
repetitions; GMFCS, Gross Motor Function Classification System; MACS, Manual Ability Classification System; ARAT, Action Research Arm Test; (M)AS, (Modified) Ashworth Score; (M)TS, 
(Modified) Tardieu score; BI, Brunnstrom Index; ROM, range of motion; sEMG, surface electromyography 
Table 2 Outcome parameters from instrumented tests developed from different signals at different stretch velocities 
First author Position Torque sEMG 
Lamontagne 
199843 
Low velocity Low and high velocity High velocity 
Average angular velocity at -5° plantarflexion Average torque at -5° plantarflexion EMG onset was defined when EMG > 2SD than mean 
baseline level preceding onset High velocity  
Maximum angular velocity  
Wu 201027 30˚/sec 30˚/sec 90,180, 270°/s  
ROM Slope of torque-angle curve at 70° elbow flexion EMG onset angle 
AOC = angle at maximum (dr(T)/dt) Energy loss: area between ascending and descending 
limbs of torque-angle curve 
 
Ratio between AOC and ROM 
 Torque at 45°, 60°, 75° elbow flexion  
 At 90,180, 270°/s  
 Slope of peak torque vs. 3 stretch velocities  
 Peak torque  
 Maximum (dr(T)/dt)  
Voerman 200735 Slow 30, 60, 90cycles/min (180, 360, 540°/s) 30, 60, 90 cycles/min (180, 360, 540°/s) 
Passive wrist ROM Slope of torque-angle curve from neutral to full wrist 
extension 
Average RMS-EMG from neutral to full wrist extension 
30, 60, 90cycles/min (180, 360, 540°/s) 
Passive wrist extension ROM   
Angular velocity   
Van der Salm 
200542 
<70°/s <70°/s 50, 75, 100 °/s 
ROM Average torque in 3 zones over the full ROM Average RMS-EMG over 100ms window after EMG 
onset (>3SD) plotted against stretch velocities, 
exponential fit over 30-45 values 
High velocity  Angle and angular velocity at EMG onset 
ROM  Slope values of angle/velocity onsets 
Average maximum angular velocity  Angle at 100°/s = reflex initiating angle 
Bar-On 201245 Low velocity  Peak of three MVICs 
ROM Low and high velocity Low and high velocity 
 Average maximum angular velocity Change in average torque at maximum velocity between 
velocity trials 
Change in in average RMS-EMG in maximum velocity 
zone (200ms before max. velocity to 90% ROM) between 
velocity trials (expressed as % of peak value of three 
maximum voluntary isometric contractions) 
 Change in average integral of torque-angle curve from 
max. velocity to 90% ROM between velocities 
   EMG onset defined as time of first muscle activity 
according to method of Staude & Wolf63 
  
Bar-On 2013 Low velocity Low and high velocity Low and high velocity 
ROM Change in average torque at 70° knee flexion between 
velocity trials 
Change in in average RMS-EMG in maximum velocity 
zone (200ms before max. velocity to 90% ROM) between 
velocity trials High velocity Change in average integral of torque-angle curve from 
max. velocity to 90% ROM between velocity trials Average maximum angular velocity 
AOC defined as the angle corresponding to the time of 
minimum power after maximum power during first high 
velocity stretch, expressed as % of ROM 
High velocity  
Minimum power after maximum power in first high 
velocity stretch 
 
 
Pandyan 200613 Slow and fast Slow and fast Slow and fast  
ROM Change in slope of force-angle curve between velocities 
over full ROM 
Change in RMS-EMG over full ROM between velocities 
Average angular velocity 
First author Position Torque sEMG 
Lebiedowska 
200947  
0.2-1.5 rad/s (11.5˚/s - 540˚/s) 0.2-1.5 rad/s (11.5-540˚/s) 0.2-1.5 rad/s (11.5-540˚/s) 
Passive ROM Slope of torque-angle curve during initial increase Maximum value of RMS-EMG over ROM 
 Slope of RMS-EMG velocity curve 
 Integral of torque-angle curve over full ROM Hypertonia of neural origin: RMS-EMG ≥ mean ± 3SD 
before movement began in slow and fast velocity 
stretches. 
 Hypertonia of non-neural origin:  RMS-EMG < mean ±3 
SD before movement began in slow and fast velocity 
stretches. 
Fleuren 20107  Slow Slow and fast Slow and fast 
Passive ROM Integral of torque-time curve over full ROM Average RMS-EMG over full ROM 
Malhotra 200837 Slow and fast  Slow and fast Slow and fast 
ROM Slope of force-angle curve 10-90% ROM Average RMS-EMG over full ROM 
 Shapes of force-angle curves: Patterns of muscle response: 
 • Slope of force-angle curve <0.7N/˚: neg. 
stiffness. 
• No/negligible muscle response 
 • Slope of force-angle curve > 0.7N/˚ and 
R2>0.6: linear stiffness 
• Position-dependent: muscle response 
independent of stretch velocity 
 • Slope of force-angle curve >0.7N/˚and R2<0.6: 
catch or clasp-knife): non-linear stiffness 
• Velocity-dependent: negligible muscle activity 
during slow stretch, increased activity during fast stretch 
 • Position- and velocity-dependent 
 • Early catch: early muscle activation reducing 
as the muscle lengthens 
Chen 200538 1/3, 1/2, 1, 1.5Hz (120˚/s, 180˚/s, 360˚/s, 540˚/s) 1/3, 1/2, 1, 1.5Hz (120˚/s, 180˚/s, 360˚/s, 540˚/s) 1, 1.5Hz (360˚/s, 540˚/s) 
ROM Velocity-dependent viscous component of torque (see 
appendix Chen 2005) 
Angle at EMG onset 
 Slope of viscosity-velocity graph (see Chen 2004)  
Turk 200839 0.5Hz (28.6˚/s) 0.04Hz (14.4˚/s). 1.5Hz (540˚/s) 
Tracking index: ability to accurately follow tracking signal Force/torque angle index: average change in 
force/torque between 0 and 30° wrist extension 
Stretch Index: average RMS-EMG minus resting EMG 
during wrist extension ROM 
Alhusaini 201044  Slow  Slow  Fast 
ROM Contracture: angle <10° dorsiflexion at 4.6Nm of force Average, normalized RMS-EMG 
Ada 199840 None 0.5, 1, 1.5, 2Hz (180, 360, 540, 720°/s) 0.5, 1, 1.5, 2Hz (180, 360, 540, 720°/s) 
 Change in torque over 20° interval Gain in RMS-EMG over ROM (µV/°) 
Vattanaslip 200041 Undefined low velocity 2Hz (720°/s) 2Hz (720°/s) 
 ROM Change in torque over 20° interval Gain in RMS-EMG over ROM (µV/°) 
ROM, range of motion; AOC, angle of catch; dr(T)/dt, change in torque over change in time; sEMG, surface electromyography; RMS-EMG, root mean square electromyography; MVIC, maximum 
isometric voluntary contraction; neg., negligible
Table 3. COSMIN scores and reasoning for scores on the reliability of included studies (for an extended version including statistical findings, see SuppInfo2) 
First author Inter-rater reliability Intra-rater reliability Measurement error 
Lamontagne 199843 Not performed Within one session, 1sec between repetitions Within one session, 1 sec between repetitions 
COSMIN score NA Poor Fair 
  - only biomechanical parameter assessed for reliability; - short 
time interval between repetitions 
- the absolute measurement error was not provided; - only 
biomechanical parameter assessed for reliability 
Generalizability NA Good Good 
  - no information on missing values - no information on missing values 
Wu 201027 Not performed 1 day between measurements Not calculated 
COSMIN score NA Fair NA 
  - only biomechanical parameter assessed for reliability  
Generalizability NA Poor NA 
  - reliability was only measured in typically developing children 
(the results cannot be generalized to a patient population) 
 
Voerman 200735 1 day between measurements 10 minutes between measurements  Not calculated 
COSMIN score Fair Good NA 
 - small sample - unclear whether administrations were independent  
Generalizability Good Excellent NA 
 - subjects were missing an ARAT score 
Van der Salm 
200542 
Not performed Within one session, 5 seconds rest between repetitions Not calculated 
COSMIN score NA Poor NA 
  - short time interval between repetitions; - only one parameter 
was assessed for reliability 
 
Generalizability NA Excellent NA 
Bar-On 201245 Not performed Average of 13 SD 9 days between measurements Average of 13 SD 9 days between measurements 
COSMIN score NA Good Good 
- small sample size; - no indication if subjects were stable in 
interim period 
 – small sample size. - no indication if subjects were stable in 
interim period. - MIC not reported 
Generalizability NA Excellent Excellent 
Bar-On 201346  Not performed (0) Average of 13 SD 9 days between measurements Average of 13 SD 9 days between measurements 
COSMIN score NA Good  Good 
  - no indication if subjects were stable in interim period  - no indication if subjects were stable in interim period . - MIC 
not reported 
Generalizability NA Excellent Excellent 
Turk 200839 Immediately following assessment by first rater  Interval of one measurement procedure (time not specified)  Intra-rater stroke:  
COSMIN score Good Good Good 
 - no ICC values calculated - time interval between administrations unknown - for some parameters average difference between persons 
with disabilities and controls >SDC. - MIC not reported 
Generalizability Excellent Excellent Excellent 
Pandyan 200164  Not performed (0) Within one session, 10-15 sec between repetitions Not calculated (0) 
COSMIN score NA Poor NA 
  - only biomechanical parameter assessed for reliability; - short 
time interval between repetitions; - no ICCs calculated 
 
Generalizability NA Excellent NA 
NA, Not Applicable; SDC, Smallest Detectable Change; MIC. Minimally Important Change; ICC, Intra Correlation Coefficient
Table 4. COSMIN scores and reasoning for scores on the validity of included studies (for an extended version including results and statistical findings, see SuppInfo 3) 
First author  Content Validity Construct validity/hypothesis testing Responsiveness  Interpretability 
Lamontagne 
199843 
Not measured Comparison to motor-controlled device Not measured Means and standard deviations of 
outcome parameters provided 
COSMIN score  NA Fair NA Good 
 - small sample; - high velocity stretches not 
comparable between hand-held dynamometer and 
motor-controlled device; – description of the 
parameters of a motor-controlled device missing 
 - small sample; -SDC and MIC not 
reported; – limited focus 
Generalizability  NA Good NA Good 
 - small sample  - small sample 
Wu 201027 Relation between signals Comparison to control group Not measured Means and standard deviations of 
outcome parameters provided Relation of signals to velocity Comparison to clinical scales  
COSMIN score  Good  Good  NA Fair  
- type of cerebral palsy (spastic, dystonia, etc) 
not mentioned, - no description of missing data  
- parametric statistics performed to compare groups 
while sample size was relatively small and data 
distribution not reported 
 - no description of missing data; SDC 
and MIC not reported 
Generalizability  Good Good  NA Good 
- type of cerebral palsy and study setting not 
mentioned 
- type of cerebral palsy and study setting not 
mentioned 
 - type of CP and study setting not 
mentioned 
Voerman 
200735 
Relation of signals to velocity Comparison to control group Not measured Means and standard deviations or 
medians and ranges of outcome 
parameters provided 
 Comparison to motor-controlled device  
COSMIN score  Fair  Good  NA Good  
- theoretical framework described but statistical 
comparisons not performed 
- the sample size used for the correlations with 
ARAT was small; - the measurement properties of 
the motor-controlled device/comparator instrument 
were not described 
 - SDC and MIC not reported 
Generalizability  Poor  Good  NA Good  
- no data on content validity available - fewer subjects tested with ARAT and with the 
motor-controlled device 
 - fewer subjects tested with ARAT and 
with the motor-controlled device 
Van der Salm 
200542 
Relation between signals Not measured Not measured Means and standard deviations of 
outcome parameters provided Relation of signals to velocity   
COSMIN score  Fair  NA NA Good  
- torque only measured in 4 subjects and only at 
low velocity 
  - small sample; -SDC and MIC not 
reported 
Generalizability  Good  NA NA Good 
- characteristics of excluded subjects missing   - torque only measured in 4 subjects 
Bar-On 201245 Relation of signals to velocity Comparison to control group Not measured Means and standard deviations of 
outcome parameters provided, SDC 
could be calculated 
  Comparison to clinical scales  
COSMIN score  Poor Good NA Good 
- no statistical tests performed - Hypotheses not explicitly stated  - MIC not reported 
Generalizability  Fair Excellent NA Excellent 
- little data on content validity available    
First author  Content Validity Construct validity/hypothesis testing Responsiveness  Interpretability 
Bar-On 201346 NA Comparison to clinical scales Treatment with BTX Means and standard deviations of 
outcome parameters provided, SDC 
provided 
COSMIN score  NA Excellent Excellent Good 
   - MIC not reported 
Generalizability  NA Excellent Excellent Excellent 
Pandyan 
200613 
Relation between signals Comparison to clinical scales: Not measured Medians and ranges of outcome 
parameters provided Relation of signals to velocity:   
COSMIN score  Excellent Good NA Good  
 - no description of how missing data was handled  - SDC and MIC not reported 
Generalizability  Excellent Excellent NA Excellent 
Lebiedowska 
200947 
Comparison between signals Comparison to control group Not measured Means and standard deviations of 
outcome parameters provided Relation of signals to velocity: 
COSMIN score  Fair Fair NA Fair 
- see comments on relation of signals to velocity 
in Suppinfo3; -statistical comparisons involving 
small samples 
- the excluded subjects’ characteristics were not 
described; -EMG data was not normalized 
 - subgroup comparisons based on small 
samples; -SDC and MIC not reported 
Generalizability  Fair Fair NA Fair 
- no diagnostic information, indication of 
spasticity severity, or functional level provided; - 
influence of heterogeneity between subjects not 
checked for 
- no diagnostic information,  indication of spasticity 
severity, or functional level provided; -Influence of 
heterogeneity between subjects not checked for 
 - subgroup comparisons based on small 
samples 
Fleuren 20107 Relation between signals Comparison to clinical scales Not measured Means and standard deviations of 
outcome parameters not provided Relation of signals to velocity   
COSMIN score  Good Good NA Poor 
- the instrumented parameters were correlated to 
the velocity of stretch with the intention of 
explaining the variability in performance rather 
than to test content validity; - muscle activity from 
antagonist muscles not measured 
- the instrumented parameters were correlated to 
the AS with the intention of explaining the variability 
in performance rather than to test construct validity; 
- large influence of rater on multivariate mixed 
linear model with AS as dependent variable 
 - no instrumented data on spasticity 
presented; -SDC and MIC not reported 
Generalizability  Good Good NA Good 
- disease characteristics not reported - disease characteristics not reported  - disease characteristics not reported 
Malhotra 
200837 
Relation between signals Comparison to clinical scales Not measured Means and standard deviations of 
outcome parameters provided Relation of signals to velocity   
COSMIN score  Excellent Good NA Good 
 - no information on missing data  - SDC and MIC not reported 
Generalizability  Excellent Excellent NA Excellent 
Chen 200538 Relation of signals to velocity Comparison to clinical scales Treatment with BTX Means and standard deviations of 
outcome parameters provided 
COSMIN score  Poor Poor Poor  Fair 
- no statistical tests carried out - no statistical tests carried out; - no information on 
missing data 
- EMG parameter was compared 
pre-post on individual subject 
data rather than with group 
analysis; - some comparisons 
made using independent, rather 
than dependent group analyses 
- no information on missing data -No 
analysis of sub-groups;- important 
statistical flaws; -SDC and MIC not 
reported 
First author  Content Validity Construct validity/hypothesis testing Responsiveness  Interpretability 
Generalizability  Good NA  Good  Good 
- no information on missing data   - no information on missing 
data 
- no information on missing data 
Turk 200839 Not measured Comparison to control group Not measured Means and SD deviations of outcome 
parameters provided. SDC can be 
calculated. 
   
COSMIN score  NA Good NA Excellent 
 -The magnitude of expected differences between 
groups were not included in the hypotheses 
  
Generalizability  NA Excellent NA Excellent 
Alhusaini 
201044 
Relation of signals to velocity Comparison to clinical scales Not measured Means and SD deviations of outcome 
parameters not provided.  
COSMIN score  Poor Good NA Poor 
- no statistical tests carried out - no description regarding missing data; -The 
magnitude of expected correlations were not 
included in the hypotheses; - stretch velocities not 
reported 
 - no values from the instrumented test 
were reported; - SDC and MIC not 
reported 
Generalizability  Excellent Excellent NA Excellent 
Ada 199840 Relation between signals Comparison to control group NA Means and standard deviations of 
outcome parameters provided 
COSMIN score  Fair Good NA Good 
- sub-group analyses were based on small 
samples; - some missing statistical results 
- some missing statistical results; - no hypotheses 
on expected result; - no information on how missing 
values were handled 
 - SDC and MIC not reported; - some 
samples too small; - the percentage of 
responders who had lowest/highest 
possible scored not reported 
Generalizability  Excellent Excellent NA Excellent 
Vattanaslip 
200041 
Relation between signals Comparison to control group NA Not all means and standard deviations 
of outcome parameters provided  
 Comparison to clinical scales  
COSMIN score Good Poor NA Poor 
- spasticity not defined - low velocity stretch to evaluate ROM not defined; - 
gain in RMS-EMG not compared between groups; - 
change in torque was only assessed at high 
velocity; -no actual comparison to clinical scale as 
parameter values not compared to clinical scores;  
 - Missing some descriptive statistics 
related to contracture and spasticity; - 
SDC and MIC not reported 
Generalizability Good Good NA Good 
- Gender of included subjects not reported; - 
Place from which subjects were recruited not 
mentioned. 
- Gender of included subjects not reported; - Place 
from which subjects were recruited not mentioned. 
 - Gender of included subjects not 
reported; - Place from which subjects 
were recruited not mentioned. 
NA, not applicable; SDC, smallest detectable change; MIC, minimally important change; ARAT, Action Research Arm Test; BTX, botulinum Toxin-A; EMG, electromyography; RMS-EMG, root mean 
square electromyography; AS, Ashworth Scale; ROM, range of motion 
